Many in the field argue that these cases may represent phenocopies of RB1 loss—through mechanisms such as CDK4/6 hyperactivation, p16INK4A loss, or functional inactivation via upstream deregulation—rather than truly RB1-proficient SCLC [38,94]. The gene discussed is CDK4; the disease is small cell lung carcinoma.